Best Hypertension Medications For Men On Testosterone
Timeline
Timestamp
Topic
00:00
Dr. O’Connor introduces the best hypertension medications for men on testosterone and explains why protecting blood pressure is essential for the heart, kidneys, brain, erections, and long-term health.
09:25
The presentation explains how testosterone exposure can raise blood pressure through sodium and water retention, kidney effects, sympathetic activation, vascular tone, sleep apnea, obesity, insulin resistance, and the renin-angiotensin-aldosterone system.
13:20
Dr. O’Connor introduces telmisartan as his primary blood-pressure medication for many men on testosterone and discusses ARB therapy, individualized dosing, nighttime blood-pressure control, metabolic effects, and kidney and cardiovascular protection.
25:40
Amlodipine is presented as another major hypertension option that can be combined with an ARB such as telmisartan, particularly when additional blood-pressure reduction is needed without substantially lowering heart rate.
29:50
Dr. O’Connor reviews thiazide-type diuretics and explains why he increasingly favors very low-dose indapamide as an add-on while remaining cautious about erectile dysfunction, electrolyte effects, and more aggressive diuretic use.
37:10
Nebivolol is discussed as Dr. O’Connor’s preferred beta blocker for selected men because it lowers heart rate and blood pressure while also promoting nitric-oxide-mediated vasodilation and potentially preserving erectile function better than conventional beta blockers.
Video Summary
Men on testosterone need blood-pressure treatment that protects the heart, kidneys, brain, and sexual function. Dr. O’Connor explains why hypertension is a critical part of long-term TRT care and reviews how testosterone can raise blood pressure through sodium and water retention, kidney effects, sympathetic activation, vascular tone, sleep apnea, obesity, and insulin resistance.
He then presents his medication hierarchy, beginning with telmisartan and discussing amlodipine, low-dose indapamide, and nebivolol as options he commonly considers depending on the individual patient. The discussion emphasizes combining lower doses strategically rather than simply maximizing one medication, while also accounting for erectile function, heart rate, kidney disease, cardiovascular disease, age, and lifestyle.
Dr. O’Connor also discusses tadalafil and Jardiance as medications that may influence blood pressure while serving other medical purposes. Throughout the presentation, he emphasizes reducing excessive testosterone exposure, losing excess weight, limiting sodium, exercising, avoiding smoking, moderating alcohol, and using the ABCDs™ to protect long-term cardiovascular, kidney, metabolic, and sexual health.
Drug Callouts
Drug
Description
Testosterone
Testosterone is central to the presentation because Dr. O’Connor explains that androgen exposure can raise blood pressure through fluid retention, kidney effects, vascular tone, sympathetic activation, and other mechanisms. He emphasizes reducing excessive testosterone dosing as part of managing hypertension rather than relying only on additional medications.
Telmisartan
Telmisartan is Dr. O’Connor’s primary antihypertensive choice for many men on testosterone. He discusses its ARB effects, kidney and cardiovascular protection, long half-life, possible metabolic benefits, potential attenuation of androgen-induced erythrocytosis, and generally favorable sexual side-effect profile.
Amlodipine
Amlodipine is discussed as a long-acting calcium channel blocker that can be added to telmisartan when more blood-pressure control is needed. Dr. O’Connor considers it effective but notes that ankle or lower-leg edema can occur as the dose increases.
Indapamide
Indapamide is presented as Dr. O’Connor’s preferred low-dose thiazide-type add-on in selected patients. He describes using small doses synergistically with other antihypertensive medications rather than automatically maximizing a single drug.
Nebivolol
Nebivolol is Dr. O’Connor’s preferred beta blocker for selected hypertensive men on testosterone, particularly when heart rate is also elevated. He emphasizes its beta-1 selectivity and nitric-oxide-mediated vasodilation while contrasting its sexual side-effect profile with conventional beta blockers.
Jardiance (Empagliflozin)
Jardiance is discussed as an SGLT2 inhibitor used for diabetes, chronic kidney disease, and heart failure rather than as a primary hypertension drug. Dr. O’Connor explains that its additional blood-pressure-lowering effect can become clinically relevant when combined with other medications.
Condition Callouts
Condition
Description
Hypertension
Hypertension is the central condition in this presentation and is described as a major modifiable cardiovascular risk for men using testosterone. Dr. O’Connor emphasizes that TRT can worsen blood pressure in some men and that persistent elevation threatens the heart, kidneys, brain, vascular system, and sexual function.
Erectile Dysfunction
Erectile dysfunction is discussed both as a consequence of vascular disease from hypertension and as a potential side effect of some antihypertensive medications. Dr. O’Connor prioritizes blood-pressure regimens for men on testosterone that control cardiovascular risk while minimizing negative effects on sexual function.
Androgen-Induced Erythrocytosis
Testosterone can increase red blood cell production and contribute to androgen-induced erythrocytosis. Dr. O’Connor discusses this within the ABCDs™ and notes that telmisartan may attenuate red blood cell production in some men while warning against confusing erythrocytosis with polycythemia vera.
Chronic Kidney Disease
Kidney health is repeatedly connected with hypertension and long-term androgen exposure. Dr. O’Connor emphasizes controlling blood pressure and recognizing proteinuria or chronic kidney disease early because renal disease and hypertension can reinforce one another in men using testosterone or anabolic steroids.
Atherosclerotic Cardiovascular Disease
Dr. O’Connor describes hypertension as a major modifiable driver of coronary artery disease, stroke, peripheral vascular disease, and other vascular complications. Men using testosterone should manage blood pressure alongside cholesterol, diabetes risk, body weight, smoking, and other components of cardiovascular risk.
Heart Failure With Preserved Ejection Fraction
Dr. O’Connor discusses heart failure with preserved ejection fraction as a condition that can emerge after years of hypertension and cardiac remodeling in older men, including those with long-term testosterone or anabolic steroid exposure. He highlights SGLT2 inhibitors such as Jardiance when discussing modern treatment for this condition.
Key Takeaways
- Testosterone can raise blood pressure through fluid retention, kidney effects, sympathetic activation, vascular changes, sleep apnea, obesity, and insulin resistance.
- Reducing excessive testosterone exposure should be considered alongside medication when hypertension develops or worsens on TRT.
- Dr. O’Connor commonly favors telmisartan as a foundation medication and adds other agents according to the patient’s individual blood pressure, heart rate, kidney health, and cardiovascular history.
- Combining appropriately selected lower-dose blood-pressure medications may provide better control and tolerability than simply maximizing one drug.
- Nebivolol may be particularly useful in selected men because it lowers heart rate and blood pressure while promoting nitric-oxide-mediated vasodilation.
- Blood-pressure management on TRT should also include weight control, exercise, sodium reduction, smoking avoidance, alcohol moderation, and monitoring of the broader ABCDs™.